STI
45
26
DHI
44
-3
SYY
49
9
EQT
51
-3
VRSK
68
-12
JBHT
56
-3
CTAS
53
-3
T
48
3
ROST
57
-3
DD
53
-6
WHR
65
-5
DIS
85
3
HAL
48
-3
AME
74
-4
NEE
54
7
MMM
35
-5
THC
60
-5
VRTX
47
-6
CNX
73
-3
TGT
45
-4
STI
45
26
DHI
44
-3
SYY
49
9
EQT
51
-3
VRSK
68
-12
JBHT
56
-3
CTAS
53
-3
T
48
3
ROST
57
-3
DD
53
-6
WHR
65
-5
DIS
85
3
HAL
48
-3
AME
74
-4
NEE
54
7
MMM
35
-5
THC
60
-5
VRTX
47
-6
CNX
73
-3
TGT
45
-4
Financhill
Back

Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
11

INO
Inovio Pharmaceuticals

Last Price:
4.27
Seasonality Move:
12.7%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Inovio Pharmaceuticals Price Quote

$4.27
+0.00 (+-10.48%)
(Updated: November 16, 2024 at 5:23 AM ET)

Inovio Pharmaceuticals Key Stats

Sell
11
Inovio Pharmaceuticals (INO) is a Sell
Day range:
$4.20 - $4.97
52-week range:
$4.20 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.14%
Volume:
668.6K
Avg. volume:
331.8K
1-year change:
-6.52%
Market cap:
$110.7M
Revenue:
$832K
EPS:
$-5.11

How Much Does Inovio Pharmaceuticals Make?

Data Unavailable

Is Inovio Pharmaceuticals Growing As A Company?

Inovio Pharmaceuticals Stock Price Performance

What Is Inovio Pharmaceuticals 52-Week High & Low?

Inovio Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inovio Pharmaceuticals?

Is Inovio Pharmaceuticals Cash Flow Positive?

  • What Is INO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$112.4M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $24.2M
  • What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $69.8M

Inovio Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    INO return on invested capital is -91.32%
  • What Is Inovio Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -70.72%
  • What Is INO Return On Equity?
    ROE is a measure of profitability and is -98.72%

Inovio Pharmaceuticals Earnings Date & Stock Price

Inovio Pharmaceuticals Competitors

Inovio Pharmaceuticals Dividend Yield

Inovio Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.38%
Revenue: -55.41% -100%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 16.80
Upside from Last Price: 293.9%

Major Shareholders

  • How many INO shares are owned by institutional investors?
    12.8M INO shares are owned by institutional investors
  • How many INO shares are owned by insiders?
    4.6M INO shares are owned by insiders